Michael Jensen

9PUBLICATIONS
101CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.

|Mar 05, 2024
Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain-containing CAR.

Samuel A Ritmeester-Loy, Isabella H Draper, Eric C Bueter

|Sep 08, 2023
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7.

Veronika Bandara, Jade Foeng, Batjargal Gundsambuu

|Oct 19, 2022
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.

Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang

|Jul 25, 2022
FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.

Peter M Sullivan, Rajesh Kumar, Wei Li

|May 17, 2022
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects.

Francesco Ceppi, Ashley L Wilson, Colleen Annesley

Pageof 2

Frequent Collaborators

4 joint publications

Wenjun Huang

4 joint publications

Julie R Park

4 joint publications

Ashley L Wilson

3 joint publications

Rimas Orentas